ARTICLE | Company News
Perlara, Novartis deal
October 31, 2016 7:00 AM UTC
Rare disease company Perlara partnered with Novartis to discover and develop therapies for lysosomal storage disorders, starting within Niemann-Pick disease type C. Novartis will receive rights to pre...